Keyphrases
Indonesia
100%
Hepatocellular Carcinoma
99%
Liver Cirrhosis
88%
Non-alcoholic Fatty Liver Disease (NAFLD)
74%
Transient Elastography
39%
Hepatocellular Carcinoma Patients
34%
Hepatitis C
31%
Hepatitis C Virus
31%
Hepatitis B Virus
30%
Cirrhosis
29%
Alpha-fetoprotein
27%
Hepatitis C Virus Infection
27%
Endoscopic Ultrasound
25%
L-ornithine-L-aspartate
24%
Asia
22%
Hepatitis B
21%
Portal Hypertension
20%
Esophageal Varices
20%
Liver Fibrosis
20%
Fibrosis
19%
Chronic Hepatitis C
19%
Chronic Hepatitis B Patients
19%
Steatosis
19%
Jakarta
18%
Nutritional Status
18%
Critical Flicker Frequency
18%
Liver Disease
18%
Hepatitis C Virus Genotypes
17%
Liver Patient
17%
Pada
17%
Branched-chain Amino Acids
17%
Chronic Hepatitis B
16%
Hepatitis B Virus Infection
16%
Ribavirin
16%
Sofosbuvir
16%
Risk Factors
15%
Liver Transplantation
15%
Gut Microbiota
15%
1-year Survival
15%
Chronic Liver Disease
14%
Adult Patients
14%
Malnutrition
14%
M2BPGi
14%
α1-acid Glycoprotein
14%
Transarterial Chemoembolization
14%
Cirrhotic Patients
14%
Liver Stiffness
14%
Multivariate Analysis
14%
Disease Burden
13%
Variceal Bleeding
13%
Medicine and Dentistry
Hepatocellular Carcinoma
94%
Liver Cirrhosis
80%
Nonalcoholic Fatty Liver
59%
Prevalence
33%
Esophageal Varices
31%
Fibrosis
31%
Transient Elastography
31%
Endoscopic Ultrasound
28%
Portal Hypertension
27%
Patient Referral
26%
Hepatitis C
22%
Gut Microbiota
21%
Chronic Hepatitis B
21%
Hepatitis C Virus
21%
Hepatitis B
20%
Aspartic Acid
19%
Ornithine
19%
Cross Sectional Study
17%
Hepatitis B Virus
17%
Liver Fibrosis
16%
Varices
15%
Bleeding
15%
Alpha-Fetoprotein
15%
Hepatic Encephalopathy
15%
Critical Flicker Fusion
15%
Liver Cancer
14%
Steatosis
14%
Survival Rate
14%
Nutritional Status
13%
Disease Burden
13%
Platelet
12%
Chronic Hepatitis C
12%
Chronic Liver Disease
12%
Diseases
12%
Liver Graft
10%
Biliary Tract Drainage
10%
Mortality Rate
10%
Protein Intake
10%
Cholestasis
10%
Systematic Review
10%
Multivariate Analysis
10%
Liver Disease
10%
Maturity Onset Diabetes of the Young
10%
Health Care Cost
9%
Brain Disease
9%
Cancer
9%
Clinical Significance
9%
Hypoglycemia
9%
Small Intestinal Bacterial Overgrowth
9%
Overall Survival
9%
Pharmacology, Toxicology and Pharmaceutical Science
Liver Cell Carcinoma
92%
Liver Cirrhosis
73%
Nonalcoholic Fatty Liver
59%
Hepatitis C
37%
Hepatitis C Virus
35%
Hepatitis B Virus
32%
Prevalence
30%
Liver Fibrosis
28%
Diseases
28%
Hepatitis B
27%
Fibrosis
24%
Ornithine
24%
Aspartic Acid
24%
Chronic Hepatitis C
22%
Liver Disease
20%
Chronic Hepatitis B
20%
Hepatic Encephalopathy
20%
Branched Chain Amino Acid
17%
Alpha Fetoprotein
16%
Ribavirin
16%
Sofosbuvir
16%
Infection
16%
Portal Hypertension
15%
Intestine Flora
15%
Liver Cancer
15%
Cross-Sectional Study
14%
Orosomucoid
14%
Inflammation
13%
Survival Rate
12%
Overall Survival
12%
Hemodialysis
11%
Daclatasvir
11%
Sorafenib
11%
Albumin
11%
Alanine Aminotransferase
11%
HIV
11%
Non Insulin Dependent Diabetes Mellitus
10%
Steatosis
10%
Chronic Liver Disease
9%
Brain Disease
9%
Binding Protein
9%
Combination Therapy
9%
Transthyretin
9%
Chronic Hepatitis
9%
Interferon
8%
Antivirus Agent
8%
Virus Hepatitis
7%
Virus Infection
7%
Bleeding
7%
Mortality Rate
7%